EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C11H16N2O3 |
| Net Charge | 0 |
| Average Mass | 224.260 |
| Monoisotopic Mass | 224.11609 |
| SMILES | C=CCC1(C(C)C)C(=O)NC(=O)N(C)C1=O |
| InChI | InChI=1S/C11H16N2O3/c1-5-6-11(7(2)3)8(14)12-10(16)13(4)9(11)15/h5,7H,1,6H2,2-4H3,(H,12,14,16) |
| InChIKey | AXJXURWWUFZZKN-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Biological Role: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| Application: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| enallylpropymal (CHEBI:134920) is a barbiturates (CHEBI:22693) |
| Synonyms | Source |
|---|---|
| 5-Allyl-5-isopropyl-1-methylbarbituric acid | DrugCentral |
| narconumal | DrugCentral |
| Manual Xrefs | Databases |
|---|---|
| 3448 | DrugCentral |
| Registry Numbers | Sources |
|---|---|
| CAS:1861-21-8 | DrugCentral |